Trials / Recruiting
RecruitingNCT05189860
The C-MIC-II Follow-Up Study
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 31 (estimated)
- Sponsor
- Berlin Heals GmbH · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The C-MIC System is a medical device used to treat heart failure per the intended purpose which is to treat heart failure by applying an electrical micro-current to the heart. Target patients for this study are patients who have received the device in a prior study.
Detailed description
The C-MIC System is a medical device used to treat heart failure per the intended purpose which is to treat heart failure by applying an electrical micro-current to the heart. The therapy with the C-MIC System is intended to take 6 months. The C-MIC System consists of four parts, of which three are implanted: a transvenous and an epicardial lead and a power source to which the leads are connected. Both leads have the function to transmit micro-current to the heart. A Portable User Terminal (PUT) is needed for programming and readout of the data recorded by the Implantable Microcurrent Device (IMD). Target patients of the C-MIC System at the time of implantation and inclusion in the C-MICII Study were patients with idiopathic dilative cardiomyopathy (NYHA class III - NYHA class who have systolic left ventricular dysfunction despite adequate therapy of heart failure. Target patients for this study are patients who have received the device in a prior study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | C-MIC system | This study aims to follow up patients already treated with a C-MIC System over a period of 2 years following the initial treatment with the device, to assess the long term results. |
Timeline
- Start date
- 2022-03-03
- Primary completion
- 2026-11-15
- Completion
- 2026-11-15
- First posted
- 2022-01-13
- Last updated
- 2025-06-08
Locations
6 sites across 4 countries: Bosnia and Herzegovina, Croatia, North Macedonia, Serbia
Source: ClinicalTrials.gov record NCT05189860. Inclusion in this directory is not an endorsement.